First | Prev | Page 1 / 4 | Next | Last

FAST BioMedical Raises $8 Million as part of Series A2 Financing Round

Posted 12:29 AM by
Carmel, Indiana – May 3, 2017 – FAST BioMedical, Inc. today announced it has secured $8 million of additional financing.  $5 million comes from a Series A2 Financing led by one new investor, F&M Investment Office.  This financing augments $3 million of grant funding received as a competing renewal award from the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health.  The proceeds will primarily be used to advance clinical trials of the company’s technology as well as to hire additional talent and advance the company’s global patent portfolio. “This financing is an important and validating step to continue our progress,” said Joe Muldoon, FAST BioMedical Chief Executive Officer.  “We have already begun adding talent to the team,... Read more →
link

Family Offices Invest for Strong Returns in Life Saving Innovations

Posted 1:31 PM by
ALIVE AND WELL: MEDTECH UNDER THE MICROSCOPE ARTICLE |  16 AUGUST, 2016 05:32 PM  Despite a reputation for being high-risk, the MedTech sector boasts above-average historical returns, strong returns on capital, and innovations that can improve quality of life. CampdenFO looks at three families that have ‘hit the vein’ When Elizabeth Holmes (pictured right) was a 19-year-old sophomore at Stanford University in 2003, she decided to drop out and start her own company, Theranos. Through her proprietary blood-testing device, which requires a few drops of blood rather than cumbersome vials, she became the world’s youngest self-made female billionaire. Today she sits disgraced, under investigation by US authorities, and facing more than nine lawsuits from disgruntled customers. Questions regarding... Read more →
link

Medical Director Dr. Molitoris pens Kidney News Online Blog Post:"Perspective: Why Nephrology Needs a Blockbuster Therapeutic

Posted 2:52 PM by
Perspective: Why Nephrology Needs a Blockbuster TherapeuticBy Bruce A. Molitoris MD FASN   "So what motivates medical students prior to, during and following their formal training? I believe this centers on a dedication to helping people by integrating science and medicine, and delivering a product consisting of diagnostic and therapeutic options, understanding and empathy."  Dr. Molitoris   Multiple factors have been described as contributors to the declining lack of interest in a nephrologycareer. These range from too intellectually challenging to income and life style considerations. However, I believe we are not considering a basic premise of why individuals choose a career in health care. The pursuit of a career in medicine is a long, demanding and arduous road. Medical school, residency and, for the majority, fellowship training... Read more →
link

FAST BioMedical Medical Director Dr. Bruce Molitoris presents at 2015 AKI & CRRT Meeting

Posted 12:32 PM by
FAST BioMedical Medical Director Dr. Bruce Molitoris recently presented at the 2015 AKI & CRRT Meeting in San Diego, California. Dr. Molitoris focused on three major points during his talk: •             The clinical importance of quantifying mGFR, as well as challenges in doing so. •             The necessity of quantifying mGFR in clinical trials in AKI and CKD •             The improved sensitivity of measuring total GFR as a stimulated GFR that maximizes                        renal function through recruitment of renal reserve.  The increasing importance of the need for a better method of measuring GFR, as well as the need for increased sensitivity to the GFR has become a major talking point in recent years.  It is believed that these measurements can positively and significantly affect patient care, specifically in AKI and solid... Read more →
link

FAST BioMedical Presents at Cutting Edge of Transplantation Meeting

Posted 3:32 PM by
FAST BioMedical was recently invited to present, as one of seven innovations, at the Cutting Edge of Transplantation (CEOT) meeting. FAST BioMedical’s technology for quickly assessing kidney function could assist in monitoring the function of a potential donor’s kidney as well as help to illuminate cadaver donor renal recovery prior to transplantation. For post-transplant patients the technology could help provide additional early quantitative indication of graft function loss and could assist in the titration of drugs, such as immunosuppressants. FAST BioMedical President Jim Strickland observed that: “With the number of patients currently seeking an organ transplant far outpacing the availability of donor organs, it is imperative that all possible care is taken to ensure that every transplantation is successful. FAST BioMedical’s... Read more →
link
First | Prev | Page 1 / 4 | Next | Last